Decreased Levels of Constitutive Proteasomes in Experimental Autoimmune Encephalomyelitis May Be Caused by a Combination of Subunit Displacement and Reduced Nfe2l1 Expression

Overview

Journal J Neurochem

Specialties Chemistry
Neurology

Date 2019 Nov 12

PMID 31709534

Citations 2

Authors

Kara L Shanley

Che-Lin Hu

Oscar A Bizzozero

Affiliations

Soon will be listed here.

Abstract

The goal of this study was to determine if subunit displacement and/or alterations in proteasome biosynthesis could explain the changes observed in the levels of constitutive proteasomes (c-20S) and immunoproteasomes (i-20S) in the spinal cords of mice with experimental autoimmune encephalomyelitis (EAE). To this end, EAE was induced in C57BL/6 mice by immunization with MOG peptide. Spinal cords were collected at different times during the disease course and used for western blotting, RNA analysis, and immunohistochemistry. The results show that, as expression of i-20S and the activator PA28 rise in EAE, there is a concomitant decline in that of c-20S at the mRNA and protein level. These changes are observed in neurons and astrocytes but not in oligodendrocytes. The increased amounts of the i-20S-specific subunit β5i and PA28α/β in EAE correlate with the levels of interferon-γ and its downstream effectors p-signal transducer and activator of transcription 1 and interferon regulatory factor-1, but not with those of nuclear factor kappa-light-chain-enhancer of activated B cells. This suggests that the signal transducer and activator of transcription 1/interferon regulatory factor-1 pathway is solely responsible for the induction of these subunits. The decrease in the mRNA and protein levels corresponding to the c-20S-specific subunit β5 may also be due to reduced expression of the nuclear factor (erythroid-derived 2)-like-1 (Nrf1 or Nfe2l1), specifically Nrf1α and Nrf1β. Low Nfe2l1 mRNA expression is unlikely caused by reduced mammalian target of rapamycin signaling but could be the result of diminished pre-B-cell leukemia homeobox-1 transcription factor levels. Together, these findings suggest that a combination of subunit displacement and reduced Nrf1 expression may be responsible for c-20S impairment in EAE. The present work provides insights into the dynamics of proteasome expression in the CNS of EAE mice and is the first to explore Nrf1 signaling in an inflammatory demyelinating disorder.

Citing Articles

Metabolic signature and proteasome activity controls synovial migration of CD14 cells in rheumatoid arthritis.

Malmhall-Bah E, Andersson K, Erlandsson M, Silfversward S, Pullerits R, Bokarewa M Front Immunol. 2023; 14:1187093.

PMID: 37662900 PMC: 10469903. DOI: 10.3389/fimmu.2023.1187093.

Proteasome Composition in Cytokine-Treated Neurons and Astrocytes is Determined Mainly by Subunit Displacement.

Shanley K, Hu C, Bizzozero O Neurochem Res. 2020; 45(4):860-871.

PMID: 31939090 DOI: 10.1007/s11064-020-02958-8.

References

Villaescusa J, Li B, Toledo E, Rivetti di Val Cervo P, Yang S, Stott S . A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease. EMBO J. 2016; 35(18):1963-78. PMC: 5282836. DOI: 10.15252/embj.201593725. View

Kuerten S, Kostova-Bales D, Frenzel L, Tigno J, Tary-Lehmann M, Angelov D . MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum. J Neuroimmunol. 2007; 189(1-2):31-40. PMC: 2083209. DOI: 10.1016/j.jneuroim.2007.06.016. View

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. PMC: 126239. DOI: 10.1186/gb-2002-3-7-research0034. View

Heink S, Ludwig D, Kloetzel P, Kruger E . IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc Natl Acad Sci U S A. 2005; 102(26):9241-6. PMC: 1166598. DOI: 10.1073/pnas.0501711102. View

Vangala J, Dudem S, Jain N, Kalivendi S . Regulation of PSMB5 protein and β subunits of mammalian proteasome by constitutively activated signal transducer and activator of transcription 3 (STAT3): potential role in bortezomib-mediated anticancer therapy. J Biol Chem. 2014; 289(18):12612-22. PMC: 4007451. DOI: 10.1074/jbc.M113.542829. View

Hussong S, Kapphahn R, Phillips S, Maldonado M, Ferrington D . Immunoproteasome deficiency alters retinal proteasome's response to stress. J Neurochem. 2010; 113(6):1481-90. PMC: 2909641. DOI: 10.1111/j.1471-4159.2010.06688.x. View

Hu C, Nydes M, Shanley K, Pantoja I, Howard T, Bizzozero O . Reduced expression of the ferroptosis inhibitor glutathione peroxidase-4 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurochem. 2018; 148(3):426-439. PMC: 6347488. DOI: 10.1111/jnc.14604. View

Zheng J, Bizzozero O . Decreased activity of the 20S proteasome in the brain white matter and gray matter of patients with multiple sclerosis. J Neurochem. 2011; 117(1):143-53. PMC: 3055957. DOI: 10.1111/j.1471-4159.2011.07182.x. View

Venugopal R, Jaiswal A . Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene. 1999; 17(24):3145-56. DOI: 10.1038/sj.onc.1202237. View

10.

Bugno M, Daniel M, Chepelev N, Willmore W . Changing gears in Nrf1 research, from mechanisms of regulation to its role in disease and prevention. Biochim Biophys Acta. 2015; 1849(10):1260-76. DOI: 10.1016/j.bbagrm.2015.08.001. View

11.

Burri L, Hockendorff J, Boehm U, Klamp T, Dohmen R, Levy F . Identification and characterization of a mammalian protein interacting with 20S proteasome precursors. Proc Natl Acad Sci U S A. 2000; 97(19):10348-53. PMC: 27027. DOI: 10.1073/pnas.190268597. View

12.

Groettrup M, Ruppert T, Kuehn L, Seeger M, Standera S, Koszinowski U . The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro. J Biol Chem. 1995; 270(40):23808-15. DOI: 10.1074/jbc.270.40.23808. View

13.

AKI M, Shimbara N, Takashina M, Akiyama K, Kagawa S, Tamura T . Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J Biochem. 1994; 115(2):257-69. DOI: 10.1093/oxfordjournals.jbchem.a124327. View

14.

Xiang Y, Wang M, Hu S, Qiu L, Yang F, Zhang Z . Mechanisms controlling the multistage post-translational processing of endogenous Nrf1α/TCF11 proteins to yield distinct isoforms within the coupled positive and negative feedback circuits. Toxicol Appl Pharmacol. 2018; 360:212-235. DOI: 10.1016/j.taap.2018.09.036. View

15.

Kobayashi A, Kang M, Okawa H, Ohtsuji M, Zenke Y, Chiba T . Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol. 2004; 24(16):7130-9. PMC: 479737. DOI: 10.1128/MCB.24.16.7130-7139.2004. View

16.

Pickering A, Linder R, Zhang H, Forman H, Davies K . Nrf2-dependent induction of proteasome and Pa28αβ regulator are required for adaptation to oxidative stress. J Biol Chem. 2012; 287(13):10021-10031. PMC: 3323025. DOI: 10.1074/jbc.M111.277145. View

17.

Zheng J, Dasgupta A, Bizzozero O . Changes in 20S subunit composition are largely responsible for altered proteasomal activities in experimental autoimmune encephalomyelitis. J Neurochem. 2012; 121(3):486-94. PMC: 3323733. DOI: 10.1111/j.1471-4159.2012.07699.x. View

18.

Morgan M, Liu Z . Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 2010; 21(1):103-15. PMC: 3193400. DOI: 10.1038/cr.2010.178. View

19.

Hou H, Miao J, Cao R, Han M, Sun Y, Liu X . Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway. Neurochem Res. 2017; 42(10):2831-2840. DOI: 10.1007/s11064-017-2296-7. View

20.

Yun Y, Kim K, Tschida B, Sachs Z, Noble-Orcutt K, Moriarity B . mTORC1 Coordinates Protein Synthesis and Immunoproteasome Formation via PRAS40 to Prevent Accumulation of Protein Stress. Mol Cell. 2016; 61(4):625-639. PMC: 4870089. DOI: 10.1016/j.molcel.2016.01.013. View